UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011174
Receipt No. R000013091
Scientific Title A randomized Phase II study of Carboplatin + Pemetrexed followed by Pemetrexed versus Carboplatin+Pemetrexed followed by Erlotinib in patients with advanced Non-squamous and Non- Small Cell Lung Cancer with EGFR sensitive mutations LOGIK1302-
Date of disclosure of the study information 2013/07/11
Last modified on 2021/01/14 09:48:52

No. Disposal Last modified on Item of update
1 Insert 2013/07/11 17:24:24
2 Update 2013/07/16 14:31:26 Institutions
3 Update 2013/10/25 10:12:11 Recruitment status
4 Update 2013/10/25 10:16:34 Email
5 Update 2014/09/09 10:01:08 Institute
6 Update 2015/01/13 13:40:38 Public title
7 Update 2016/01/12 09:11:08 Randomization unit
Interventions/Control_1
Interventions/Control_2
8 Update 2016/01/12 09:11:47 Recruitment status
9 Update 2018/01/15 09:40:17 Name of primary sponsor
Organization
10 Update 2021/01/14 09:48:52 Recruitment status
Date of IRB


Contact us.